| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 813.41B | 825.59B | 836.28B | 773.96B | 642.02B | 562.85B |
| Gross Profit | 145.45B | 148.24B | 152.13B | 133.33B | 112.93B | 83.82B |
| EBITDA | 68.72B | 65.55B | 70.17B | 59.41B | 46.15B | 32.34B |
| Net Income | -11.83B | -23.80B | 10.57B | 10.37B | 7.34B | -11.64B |
Balance Sheet | ||||||
| Total Assets | 887.59B | 856.42B | 910.25B | 869.83B | 855.48B | 836.56B |
| Cash, Cash Equivalents and Short-Term Investments | 144.46B | 131.52B | 130.03B | 111.66B | 128.64B | 154.97B |
| Total Debt | 343.35B | 370.49B | 374.48B | 388.01B | 403.55B | 430.89B |
| Total Liabilities | 593.46B | 607.72B | 629.43B | 632.40B | 639.06B | 652.81B |
| Stockholders Equity | 276.63B | 232.89B | 264.33B | 220.66B | 197.85B | 170.53B |
Cash Flow | ||||||
| Free Cash Flow | 27.82B | 22.09B | 40.38B | 14.51B | -7.38B | 14.57B |
| Operating Cash Flow | 59.40B | 45.62B | 65.10B | 34.22B | 8.96B | 36.47B |
| Investing Cash Flow | -32.79B | -25.96B | -24.97B | -13.86B | 2.51B | -17.94B |
| Financing Cash Flow | -16.70B | -18.71B | -30.21B | -33.26B | -41.30B | 54.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥732.74B | 18.30 | 9.10% | 1.63% | 6.28% | 2.62% | |
72 Outperform | ¥75.83B | 7.91 | 6.66% | 3.36% | 3.80% | -15.46% | |
72 Outperform | ¥226.12B | 10.15 | 7.86% | 2.55% | 0.57% | 4.54% | |
67 Neutral | ¥62.23B | 11.27 | ― | 2.82% | 8.75% | 177.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥109.76B | 17.03 | 2.64% | 2.30% | -4.11% | 46.76% | |
52 Neutral | ¥188.22B | 85.52 | -4.83% | 3.08% | -3.18% | -531.48% |